These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 15764714

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies.
    Wandel C, Kim RB, Kajiji S, Guengerich P, Wilkinson GR, Wood AJ.
    Cancer Res; 1999 Aug 15; 59(16):3944-8. PubMed ID: 10463589
    [Abstract] [Full Text] [Related]

  • 3. Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.
    Wandel C, Kim RB, Guengerich FP, Wood AJ.
    Drug Metab Dispos; 2000 Aug 15; 28(8):895-8. PubMed ID: 10901697
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
    Yumoto R, Murakami T, Sanemasa M, Nasu R, Nagai J, Takano M.
    Drug Metab Dispos; 2001 Feb 15; 29(2):145-51. PubMed ID: 11159804
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats.
    Perloff MD, von Moltke LL, Greenblatt DJ.
    Xenobiotica; 2004 Feb 15; 34(2):133-50. PubMed ID: 14985144
    [Abstract] [Full Text] [Related]

  • 9. Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture.
    Störmer E, von Moltke LL, Perloff MD, Greenblatt DJ.
    Pharm Res; 2002 Jul 15; 19(7):1038-45. PubMed ID: 12180537
    [Abstract] [Full Text] [Related]

  • 10. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.
    Ma B, Prueksaritanont T, Lin JH.
    Drug Metab Dispos; 2000 Feb 15; 28(2):125-30. PubMed ID: 10640508
    [Abstract] [Full Text] [Related]

  • 11. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model.
    Cummins CL, Salphati L, Reid MJ, Benet LZ.
    J Pharmacol Exp Ther; 2003 Apr 15; 305(1):306-14. PubMed ID: 12649383
    [Abstract] [Full Text] [Related]

  • 12. Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A.
    Johnson BM, Charman WN, Porter CJ.
    Drug Metab Dispos; 2003 Sep 15; 31(9):1151-60. PubMed ID: 12920171
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line.
    Zastre JA, Chan GN, Ronaldson PT, Ramaswamy M, Couraud PO, Romero IA, Weksler B, Bendayan M, Bendayan R.
    J Neurosci Res; 2009 Mar 15; 87(4):1023-36. PubMed ID: 18855943
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole.
    von Moltke LL, Durol AL, Duan SX, Greenblatt DJ.
    Eur J Clin Pharmacol; 2000 Jun 15; 56(3):259-61. PubMed ID: 10952482
    [Abstract] [Full Text] [Related]

  • 18. Effects of alkylphenols on CYP1A and CYP3A expression in first spawning Atlantic cod (Gadus morhua).
    Hasselberg L, Meier S, Svardal A, Hegelund T, Celander MC.
    Aquat Toxicol; 2004 May 12; 67(4):303-13. PubMed ID: 15084407
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.
    Kim RB, Wandel C, Leake B, Cvetkovic M, Fromm MF, Dempsey PJ, Roden MM, Belas F, Chaudhary AK, Roden DM, Wood AJ, Wilkinson GR.
    Pharm Res; 1999 Mar 12; 16(3):408-14. PubMed ID: 10213372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.